Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson's Disease

Abstract

A BS TRACT: Introduction: Parkinson's disease (PD) is a chronic neurodegenerative disorder that presents with motor and non-motor manifestations. Amongst the nonmotor features, various forms of sleep disturbances can occur, and obstructive sleep apnea (OSA) is considered to be a common comorbidity. We conducted this systematic review and meta-analysis to assess the impact of OSA on cognitive and motor functions in PD. Methods: The information sources of for this systematic review and meta-analysis were PubMed, SCOPUS, Web of Science, and ScienceDirect. Studies meeting the following criteria were included: (1) studies including idiopathic PD patients, (2) studies using polysomnography to categorize PD patients into PD with OSA and PD without OSA, and (3) studies with observational designs (casecontrol, cohort, or cross-sectional). Data analysis was performed using RevMan. Results: Our meta-analysis showed that OSA was associated with significantly lower scores of Montreal Cognitive Assessments (MoCA) (mean difference (MD) = −0.70, 95% confidence interval (CI) [−1.28, −0.13], P = 0.01) and Mini-Mental State Examination (MMSE) (MD = −0.69, 95% CI [−1.17, −0.21], P = 0.005). Moreover, the score of the motor part of the Unified Parkinson's Disease Rating Scale (UPDRS III) was significantly higher in PD patients with OSA as compared with those without OSA (MD = 1.63, 95% CI [0.03, 3.23], P = 0.049). Conclusions: OSA is associated with increased severity of PD-associated cognitive dysfunction and motor symptoms. However, further studies are needed to corroborate these findings, assess the underlying mechanisms by which OSA influences the motor and cognitive functions in PD, and investigate whether OSA can accelerate the neurodegenerative process of PD.

Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases

“…Sleep disturbances are commonly associated with neurodegenerative diseases and are known to greatly affect the quality of life of patients [ 119 ]. For example, sleep disorders, such as nighttime insomnia, daytime hypersomnia, and rapid eye movement (REM) sleep disorders, are often seen in patients with AD [ 159 , 188 ] or PD [ 77 , 253 ]. Many effective sedative-hypnotic drug products, including benzodiazepine and Z-drugs (e.g., zolpidem, zaleplon, zopiclone) are used to induce and/or maintain sleep in people with sleep disorders.…”

The Effect of Rotigotine on Cognitive Function and Sleep Problems in Parkinson's Disease: an Open-Label Pilot Study

“…Insomnia is associated with impairments in cognitive performance, and thus, relieving insomnia could potentially improve cognitive outcome [24]. A recent systematic review and meta-analysis showed that obstructive sleep apnea was associated with signi cantly lower MoCA scores in patients with PD [25]. Increased sleep fragmentation and nocturnal hypoxia are important mechanisms, contributing to impair cognition [22].…”

Extraction vs. Nonextraction on Soft‐Tissue Profile Change in Patients with Malocclusion: A Systematic Review and Meta‐Analysis

“…We extracted the following domains using an offline data extraction sheet [ 23 ]: (1) last name of first author, (2) year of publication, (3) design, (4) population characteristics, (5) sample size, (6) accessible data of studied outcomes, and (7) risk of bias.…”